The data related to these biomarkers need to be validated in future studies, followed by testing of their clinical utility for routine screening, as non-surgical diagnostic markers, and as targets for immunomodulatory therapy, with the aim of identifying immunomodulatory strategies for this disease
Research in these areas is still ongoing and requires further validation through clinical trials to confirm these effects on a broader scale
Avoid high-fat, greasy, and heavily spiced foods during the first 2 weeks at a new dose
doi: 10.1371/journal.pone.0176860 Summary Keywords gamma aminobutyric acid (GABA), Type 1 diabetes, GABA treatment/diabetes, -cells/pancreatic islets, -cells/glucagon, diabetes/new therapies, GABA-producing microbes, microbiome/GABA/glutamate Citation Mick GJ and McCormick KL (2024) The role of GABA in type 1 diabetes